Jardiance® - Chronic Kidney Disease
10 mg| Tablets
General information
From February 1, 2024, the use of Jardiance® (empagliflozin) in adult patients with chronic kidney disease, with and without diabetes type 2, is regularly reimbursed through the health insurance.
This means that the TBR for patients with chronic kidney disease will be stopped. The pharmacy or patient can declare medication dispensed in the period from July 24, 2023 to February 1, 2024 until July 1, 2024 at the latest via TBR Nederland.
| Dose | Jardiance® 10 mg |
| Type | Pill |
| Active ingredient | EMPAGLIFLOZIN |
Reimbursement
Conditions
Jardiance® (empagliflozin) 10 mg was fully reimbursed through TBR Netherlands from July 24, 2023 to February 1, 2024. Issues that took place during this period can be submitted until July 1, 2024 at the latest.
Who can submit a claim
Pharmacies, patients or their caregivers can claim the costs of Jardiance (empagliflozine) 10 mg for the treatment of chronic kidney disease online or by post. Online will be the fastest option.
From when till when can you submit a claim
The pharmacy or patient can declare medication dispensed in the period from July 24, 2023 to February 1, 2024 until July 1, 2024 at the latest via TBR Nederland.
Submit a claim online
Patients can claim online and will receive their reimbursement within 5 working days.
Submit a claim by post
Patients can claim by post and will receive their reimbursement within 15 working days.
Please mail the Claim Form and attachments to:
TBR Nederland
Postbus 8011
1180 LA Amstelveen
Need some help?
If you need any assistance please read our Frequently Asked Questions.
Still does not work? Please contact our Servicedesk via e-mail or call the Jardiance® 10 mg service-number 088-0026715.
PC-NL-105348
Check your medicine expenses
Quickly check the maximum contribution you have to pay for your medicine
